Combination Immunotherapy Improves Outcomes for BCG Unresponsive Non Muscle Invasive Bladder Cancer
Combination immunotherapy shows promise for bladder cancer patients
Multi-agent immunotherapy regimens show superior response rates and progression-free survival compared to monotherapy in patients with NMIBC…
A new combination of immunotherapies may improve response rates and survival for patients with specific types of bladder cancer.
Systematic review examines IL-15-based immunotherapy for cancer with manageable toxicity profiles
New Immune Booster Could Help Cancer Fighters Last Longer
A systematic review evaluated IL-15-based cancer immunotherapy, including recombinant IL-15 and immunocytokines, for cancer treatment.
A new immune booster helps cancer fighters stay active longer, potentially making treatments for solid tumors and CAR-T therapy work far bet…